Excite Holdings (5571) Q1 FY2027 Earnings Analysis: Media Recovery and AI-Driven Efficiency Drive 50.9% Operating Profit Growth

Excite Holdings Co., Ltd. delivered a strong start to the fiscal year ending March 2027, with its Q1 (April–June 2026) results showing solid growth in both revenue and profit at all levels, highlighted by a 50.9% year-on-year increase in operating profit . This report provides a detailed analysis of the company's performance highlights, segment-specific progress, cost structure optimization, and its medium-to-long-term growth strategy, based on the disclosed earnings presentation materials.

---

1. Q1 FY2027 Earnings Highlights

Consolidated results for the first quarter were as follows: Revenue of 2,645 million yen (+3.6% YoY) , EBITDA of 267 million yen (+57.0% YoY) , Operating Profit of 103 million yen (+50.9% YoY) , Ordinary Profit of 91 million yen (+75.8% YoY) , and Net Income Attributable to Owners of the Parent of 92 million yen (compared to a 24 million yen loss in the same period last year).

The slide above provides an overview of the group's performance and segment-level results for the quarter. The data underscores that the profit recovery in Media Services and the return to profitability in the SaaS/DX business were the primary drivers of group-wide profit growth. Furthermore, the absence of extraordinary losses that weighed on the previous quarter (a total of 101 million yen, consisting of 68 million yen in head office relocation costs and 33 million yen in business withdrawal losses) contributed to a significant improvement in net income.

Key performance indicators are as follows:

• Revenue : 2,645 million yen (YoY +3.6%)
• Operating Profit : 103 million yen (YoY +50.9%)
• Operating Profit Margin : 3.9% (YoY +1.2pt)
• EBITDA Margin : 10.1% (YoY +3.4pt)

---

2. Progress Against Full-Year Forecasts and Profit Generation Patterns

The company has set its full-year forecasts at 12,000 million yen in revenue , 1,200 million yen in EBITDA , 610 million yen in operating profit , and 350 million yen in net income attributable to owners of the parent .

As of Q1, the progress rates against these full-year targets are 22.0% for revenue , 17.0% for operating profit , and 26.5% for net income . While the 17.0% operating profit progress may appear low at first glance, the company has structured its plan to be "second-half weighted," concentrating marketing investments to expand the customer base in the first half and harvesting profits in the second half. According to management, the Q1 operating profit of 103 million yen is "ahead of internal expectations," indicating a very steady trajectory toward achieving the full-year targets.

Regarding financial health, the company maintains an equity ratio of 32.2% , ensuring a sound financial foundation while continuing to pay dividends and repay debt. The current PBR (Price-to-Book Ratio) stands at 1.38x , and the company continues to implement measures to enhance corporate value with a focus on the cost of capital.

---

3. Cost Reduction and Optimization of SG&A via AI-Driven Development

A major factor supporting the profit growth is the company-wide curbing of SG&A expenses and productivity improvements . Despite rising revenue, total SG&A expenses were reduced from 1,426 million yen in the same period last year to 1,410 million yen (a 1.1% YoY decrease) .

A breakdown of SG&A expenses in the slide above shows that outsourcing and system costs decreased from 279 million yen to 265 million yen . This is attributed to the company's active adoption of AI (AI-driven development) across the group. By integrating generative AI into operational workflows and system development, the company has dramatically increased development efficiency, directly leading to lower outsourcing and labor costs.

Advertising expenses were 550 million yen (down 3.1% YoY), reflecting a shift toward operations that strictly evaluate investment efficiency (ROAS/CPO). This has strengthened the company's ability to boost profit margins by eliminating wasteful acquisition costs.

---

4. Detailed Segment Analysis

The performance of the company's four business segments (Platform, SaaS/DX, Medical, and Broadband) is as follows:

The slide above illustrates the trend in operating profit by segment. It is clear that the profit surge in the Platform business (158 million yen, +132.5% YoY) and the stabilization of profitability in the SaaS/DX business (25 million yen) have more than sufficiently absorbed the upfront investments and cost adjustments in the Medical business (-84 million yen).

(1) Platform Business

• Revenue : 841 million yen (+1.2% YoY)
• Operating Profit : 158 million yen (+132.5% YoY)

Within this segment, Media Services achieved a dramatic recovery, with operating profit reaching 83 million yen (an improvement of 110 million yen YoY) , driven by a rebound in advertising unit prices and page views (PV). Average monthly PVs reached 463 million (+15.4% YoY) , thanks to the successful deployment of AI-produced manga content and the expansion of media partners. In Counseling Services (telephone fortune-telling, consultation services, etc.), the company prioritized profit margins over revenue scale. Consequently, while the number of consultations was 58,586 (-5.0% YoY), the repeat customer rate reached a high level of 75.3% (up from 69.2% in the previous period) , stably generating 108 million yen in operating profit (+6.5% YoY) .

(2) SaaS/DX Business

• Revenue : 250 million yen (+4.9% YoY)
• Operating Profit : 25 million yen (41 million yen improvement YoY, turning profitable)

Driven by successful new customer acquisition for the marketing support SaaS "FanGrowth" and the virtual shareholder meeting support tool "Sharely," the SaaS business turned profitable with an operating profit of 13 million yen . Furthermore, in the DX consulting and development business, the introduction of AI-driven development led to cost reductions, resulting in an operating profit of 12 million yen (+83.4% YoY) . The SaaS/DX business is establishing itself as a source of continuous recurring revenue rather than a one-time profit contributor.

(3) Medical Business

• Revenue : 635 million yen (+10.3% YoY)
• Operating Profit : -84 million yen (40 million yen decrease YoY)
• Adjusted Operating Profit : 12 million yen (compared to 72 million yen in the same period last year)

While revenue increased due to the consolidation of "ONE MEDICAL," intensified competition in web advertising within the online medical consultation market led to a surge in Customer Acquisition Cost (CPO) . The company opted to avoid reckless advertising spending and shifted toward a policy of curbing advertising ratios, leading to a temporary decline in revenue and profit compared to the previous quarter (Q4 FY2026). The current priority is improving unit economics; the company plans to strategically reinvest in high-efficiency channels once profitability is stabilized.

(4) Broadband Business

• Revenue : 918 million yen (+1.4% YoY)
• Operating Profit : 129 million yen (-7.1% YoY)

New member acquisitions for high-speed "10-gigabit" lines and MVNO services remained strong, with the average monthly paying subscriber count steadily increasing to 63,539 (+3.8% YoY) . Although operating profit saw a slight decline due to temporary advertising and customer center costs associated with member acquisition, the business remains a solid foundation that generates stable cash flow for the entire group.

---

5. Summary and Future Outlook

The Q1 FY2027 results demonstrate that Excite Holdings is executing both "strict profit-oriented management" and "structural cost reduction through AI utilization" at a high level. The company showed flexibility by quickly curbing advertising investments in response to the rising CPO in the Medical business, while simultaneously driving significant group-wide profit growth through the recovery of Media Services and the profitability of the SaaS/DX business.

Moving forward, the key focus for achieving the full-year forecast will be whether the marketing investments made in the first half translate into revenue growth in the second half, and when the Medical business will return to a growth trajectory following the improvement of its unit economics.